All In Biotech

Drug Trial Radar · NCT02604836

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate

Last checked: Nov 20, 2026Latest source record: Nov 2, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,711

Actual

Start

Jun 2004

Primary completion

Apr 2006

Study completion Apr 2006

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Nov 13, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will investigate participant satisfaction (including compliance, preference, tolerability) with once-monthly Bonviva in women with post-menopausal osteoporosis or osteopenia transitioned from once-weekly alendronate or risedronate. The anticipated time on study treatment is 6 months, and the target sample size is 1776 individuals.

Conditions

  • Postmenopausal Osteoporosis

Interventions

  • IbandronateDrug

    Film-coated oral ibandronate tablet (150 mg) once-monthly

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Number of participants who currently use weekly biphosphonate who answer "yes" to any of the questions in Candidate Identification Questionnaire (CIQ)Time frame: Up to 30 days prior to baseline visit
  2. Part B: Number of participants who demonstrate improvement from their baseline satisfaction score after 6 months of ibandronateTime frame: 6 months
  3. Part B: Percentage of participants who demonstrate improvement from their baseline satisfaction score after 6 months of ibandronateTime frame: 6 months

Locations

142 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Birmingham, Alabama

  • Site not named

    Columbiana, Alabama

  • Site not named

    Huntsville, Alabama

  • Site not named

    Mobile, Alabama

  • Site not named

    Montgomery, Alabama

  • Site not named

    Chandler, Arizona

  • Site not named

    Gilbert, Arizona

  • Site not named

    Paradise Valley, Arizona

  • Site not named

    Phoenix, Arizona

  • Site not named

    Phoenix, Arizona

  • Site not named

    Tempe, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    Carlisle, Arkansas

  • Site not named

    Jonesboro, Arkansas

  • Site not named

    Little Rock, Arkansas

  • Site not named

    Pine Bluff, Arkansas

  • Site not named

    Rogers, Arkansas

  • Site not named

    Searcy, Arkansas

  • Site not named

    Sherwood, Arkansas

  • Site not named

    Anaheim, California

  • Site not named

    Beverly Hills, California

  • Site not named

    Laguna Hills, California

  • Site not named

    Mission Viejo, California

  • Site not named

    Palm Desert, California

  • Site not named

    Palo Alto, California

  • Site not named

    Sacramento, California

  • Site not named

    San Diego, California

  • Site not named

    Tacoma, California

  • Site not named

    Vista, California

  • Site not named

    Westlake Village, California

  • Site not named

    Colorado Springs, Colorado

  • Site not named

    Lakewood, Colorado

  • Site not named

    Avon, Connecticut

  • Site not named

    Cromwell, Connecticut

  • Site not named

    Hamden, Connecticut

  • Site not named

    New London, Connecticut

  • Site not named

    Waterbury, Connecticut

  • Site not named

    Wilmington, Delaware

  • Site not named

    Aventura, Florida

  • Site not named

    Clearwater, Florida

Showing 40 of 142 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.